Cystic Fibrosis Therapeutics Market Set to Soar Past USD 12.9 Billion by 2030 The Cystic Fibrosis Market is expected to exhibit at 13.5% CAGR to reach USD 12.9 Billion over the forecast period 2023-2030
Cystic fibrosis (CF) is a genetic disorder that affects the respiratory, digestive, and reproductive systems. It is caused by mutations in the CFTR (cystic fibrosis transmembrane conductance regulator) gene, leading to the production of thick and sticky mucus...